Verici Dx: Tutivia Set to Disrupt Transplant Monitoring with Real-Time RNA Insights (Video)
Tutivia is turning heads in transplant care. Verici Dx CEO Sara Barrington explains how their RNA-based rejection test is setting new standards in real-world useāand why clinicians and payers are getting on board.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed